Symrise Ag · XETR:SY1
Symrise — Q3 2026 Earnings Presentation
22 slides from Symrise's earnings presentation, Oct 28, 2026
Slide 1: Trading Statement Q3 2026
Trading Statement Q3 2026 — Dr Jean-Yves Parisot (CEO), Olaf Klinger (CFO) October 28, 2026
Slide 2: Agenda
Agenda Overview — 1 2 3 Q3 2026 Strategy & 2026 Review Transformation Outlook Dr Jean-Yves Parisot, CEO Update Olaf Klinger, CFO 2
Slide 3: Q3 2026 Review
01 Q3 2026 Review 3
Slide 4: Q3 2026 Highlights
Q3 2026 Highlights Q3 2026 REVIEW — 1 Q3 organic sales growth of 5.3% exceeded expectations Supported by sustained business momentum and more favorable year-over-year comparables 2 Broad-based volume-led growth underscores strong execution and solid customer demand Food & Beverage continued to deliv
Slide 5: Q3 2026: Sales Performance with Broad-Based Growth Across Segments
Q3 2026: Sales Performance with Broad-Based Growth Across Segments Q3 2026 REVIEW Strong volume-driven organic sales growth and improving momentum across the portfolio — Group Taste, Nutrition & Health Scent & Care in €m in €m in €m +5.3% -0.5% +2.3% +7.2% +5.2% 0.0% +2.2% +7.4% +5.6% -1.1% +2.4% +6
Slide 6: Q3 2026 Sales by Region
Q3 2026 Sales by Region Q3 2026 REVIEW Strong continued momentum in Asia Pacific and North America, Latin America — emerging as an additional growth driver Organic sales growth by region Sales by region % of global sales 22% 24% North America +4.8% €1.310m Asia Q3 Pacific 14% EAME +12.1% +1.7% 40% L
Slide 7: Q3 Execution Highlights
Q3 Execution Highlights Continuing to drive growth while earning recognition for highest standards — Chennai Digital & AI Hub Group Symvision AI Second hub after Barcelona opened in Expanded into an end-to-end innovation September: scaling data products, platform (Trend, Consumer, Concept, Design):
Slide 8: Strategy & Transformation Update
02 Strategy & Transformation Update 8
Slide 9: Executing Our ONE Symrise Strategy and ONE SYM Transformation
Executing Our ONE Symrise Strategy and ONE SYM Transformation STRATEGY & TRANSFORMATION UPDATE ONE Symrise Strategy ONE SYM Transformation — PLANNED INNOVATE IN HEALTH, WELLBEING AND BEAUTY, PURPOSE FOR THE ENTIRE FAMILY’S EVERYDAY LIFE ACTIVE Phase 3: COMPLETED Drive WHERE PORTFOLIO: Phase 2: Momen
Slide 10: ONE Symrise in Action: Portfolio Spotlight
Portfolio ONE Symrise in Action: Portfolio Spotlight STRATEGY & TRANSFORMATION UPDATE Sharpening portfolio quality through disciplined capital allocation • Focus on higher-growth, DIVEST ACQUIRE INVEST innovation-led businesses with Focus and Simplify Strengthen and Grow Build Organically long-term
Slide 11: New Structure in Scent & Care
Portfolio New Structure in Scent & Care STRATEGY & TRANSFORMATION UPDATE A more focused organization, aligned with distinct business models and growth opportunities — What has changed NEW NEW NEW • Established three Scent Fine Consumer Products Natural focused business areas: Fragrance • Consumer Fr
Slide 12: Aroma Specialties: Focused Specialty Ingredient Platform
Portfolio Aroma Specialties: Focused Specialty Ingredient Platform STRATEGY & TRANSFORMATION UPDATE Sharpening our portfolio and enhancing operational efficiency to drive profitable growth — NEW NEW NEW Focusing on Aroma S&C Specialties Essential Signature specialty-driven, Ingredients Ingredients h
Slide 13: ONE SYM Transformation
ONE SYM Transformation STRATEGY & TRANSFORMATION UPDATE Providing foundation for long-term profitable growth through strategic reinvestments FUND INVESTMENT DRIVE ACCELERATE EFFICIENCY GROWTH Advancing operational Enhancing competitiveness by excellence to drive cost Efficiency strategically reinves
Slide 14: 2026 Outlook
04 2026 Outlook 14
Slide 15: FY 2026 Outlook and Mid-Term Targets
FY 2026 Outlook and Mid-Term Targets 2026 OUTLOOK — 2026 Outlook Mid-term Targets (2025-2028) Organic 2%-4% 5%-7% (CAGR) Sales growth EBITDA margin 21.5%-22.5% (Adjusted) 21%-23% BFCF margin >14% (Adjusted) >14% Commentary • Q4 organic sales growth expected to moderate • Multi-year growth opportunit
Slide 16: Our Continuing Commitment
Our Continuing Commitment Controlling the controllables while executing ONE Symrise Strategy and — accelerating multi-year ONE SYM Transformation 1 2 3 Enhance Drive durable, Increase competitiveness profitable growth shareholder value through the across all our through durable acceleration of the b
Slide 17: Symrise AG
Symrise AG — Financial calendar Contact 3 March 2027 Full Year Results 2026 Symrise AG Muehlenfeldstraße 1 28 April 2027 37603 Holzminden, Germany Trading Statement Q1 2027 René Weinberg Investor Relations 29 July 2027 rene.weinberg@symrise.com Interim Report January –June 2027 27 October 2027 Tradi
Slide 18: Appendix
Appendix 18
Slide 19: 9M 2026: Sales Performance
9M 2026: Sales Performance 9M 2026 REVIEW Market-leading OSG in Food & Beverage, strong performance in Fragrance — Group Taste, Nutrition & Health Scent & Care in €m in €m in €m +3.0% -0.2% -0.9% +1.9% +3.9% -0.1% -1.2% +2.5% +1.8 % -0.3% -0.4 % +1.1 % 3,776 3,850 115 -8 -33 2,263 2,320 88 -3 -28 1.
Slide 20: 9M 2026 Sales by Region
9M 2026 Sales by Region 9M 2026 REVIEW Positive development in Asia Pacific and North America, Latin America as an — additional growth driver Organic sales growth by region Sales by region % of global sales 22% 24% North America +5,3% €3.850m Asia 9M Pacific 14% EAME +9.1% -1,3% 40% Latin America NA
Slide 21: Glossary
Glossary — APAC Asia Pacific BFCF Business Free Cash Flow DD Double digit EAME Europe, Africa, Middle East FX Foreign exchange HSD High single digit LATAM Latin America LSD Low single digit LTM Last twelve months MSD Mid single digit NA North America OSG Organic sales growth 21
Slide 22: symrise
ry symrise always inspiring more